Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively (Q73595223)
scientific article published on 01 April 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively |
scientific article published on 01 April 2000 |
Statements
Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively (English)
A M Tari
G Lopez-Berestein